Page last updated: 2024-08-18

cyclohexanol and Acute Liver Injury, Drug-Induced

cyclohexanol has been researched along with Acute Liver Injury, Drug-Induced in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (20.00)	18.2507
2000's	7 (70.00)	29.6817
2010's	1 (10.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Acharya, N; D'Souza, DN; Seeger, J; Strombom, I; Wernicke, JF	1
Agudo, JL; Aniorte, JP; Arroyo, VC; Hallal, H	1
Archer, DF; Cheng, RF; Guico-Pabia, CJ; Hwang, E; Pinkerton, JV	1
Bate, A; Hägg, S; Spigset, O	1
Ozcetin, A; Sahin, I; Sencan, I	1
Chun, YJ; Hyun, SH; Jeon, TW; Jeong, TC; Jin, CH; Kim, NH; Lee, DW; Lee, ES; Lee, JS; Lee, SK	1
Beck, MG; Digmann, RR; Phillips, BB	1
Hwang, W; Kim, KY; Narendran, R	1
De Clercq, M; Horsmans, Y; Sempoux, C	1
Avila, A; Cardona, X; Castellanos, P	1

Trials

1 trial(s) available for cyclohexanol and Acute Liver Injury, Drug-Induced

Article	Year
Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopause. Menopause (New York, N.Y.), 2013, Volume: 20, Issue:1 Topics: Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Chemical and Drug Induced Liver Injury; Cyclohexanols; Desvenlafaxine Succinate; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Middle Aged; Placebos; Risk Factors; Treatment Outcome	2013

Article

Year

Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopause.

Menopause (New York, N.Y.), 2013, Volume: 20, Issue:1

Topics: Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Chemical and Drug Induced Liver Injury; Cyclohexanols; Desvenlafaxine Succinate; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Middle Aged; Placebos; Risk Factors; Treatment Outcome

2013

Other Studies

9 other study(ies) available for cyclohexanol and Acute Liver Injury, Drug-Induced

Article	Year
Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources. Current drug safety, 2008, Volume: 3, Issue:2 Topics: Adrenergic Uptake Inhibitors; Adverse Drug Reaction Reporting Systems; Chemical and Drug Induced Liver Injury; Consumer Product Safety; Cyclohexanols; Databases as Topic; Duloxetine Hydrochloride; Humans; Liver; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Thiophenes; United States; United States Food and Drug Administration; Venlafaxine Hydrochloride	2008
[Venlafaxine-induced cholestatic hepatitis]. Gastroenterologia y hepatologia, 2009, Volume: 32, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Cyclohexanols; Humans; Male; Venlafaxine Hydrochloride	2009
Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: data from the World Health Organization (WHO) database of adverse drug reactions. International clinical psychopharmacology, 2003, Volume: 18, Issue:3 Topics: Adverse Drug Reaction Reporting Systems; Bayes Theorem; Chemical and Drug Induced Liver Injury; Cyclohexanols; Databases, Factual; Humans; Neural Networks, Computer; Pancreatitis; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride; World Health Organization	2003
Low-dose venlafaxine-associated liver toxicity in chronic hepatitis. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Cyclohexanols; Dose-Response Relationship, Drug; Female; Hepatitis, Chronic; Humans; Liver Function Tests; Venlafaxine Hydrochloride	2004
Pretreatment with 1,8-cineole potentiates thioacetamide-induced hepatotoxicity and immunosuppression. Archives of pharmacal research, 2004, Volume: 27, Issue:7 Topics: Alanine Transaminase; Animals; Antibody Formation; Aspartate Aminotransferases; Blotting, Western; Body Weight; Carcinogens; Chemical and Drug Induced Liver Injury; Cyclohexanols; Drug Synergism; Erythrocytes; Eucalyptol; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; Microsomes, Liver; Mixed Function Oxygenases; Monoterpenes; Organ Size; Rats; Rats, Sprague-Dawley; Sheep; Thioacetamide	2004
Hepatitis associated with low-dose venlafaxine for postmenopausal vasomotor symptoms. The Annals of pharmacotherapy, 2006, Volume: 40, Issue:2 Topics: Chemical and Drug Induced Liver Injury; Cyclohexanols; Dose-Response Relationship, Drug; Female; Hot Flashes; Humans; Liver Function Tests; Middle Aged; Postmenopause; Venlafaxine Hydrochloride	2006
Acute liver damage possibly related to sertraline and venlafaxine ingestion. The Annals of pharmacotherapy, 1999, Volume: 33, Issue:3 Topics: Acute Disease; Adult; Antidepressive Agents; Cephalexin; Cephalosporins; Chemical and Drug Induced Liver Injury; Cyclohexanols; Drug Overdose; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide, Attempted; Venlafaxine Hydrochloride	1999
Venlafaxine-associated hepatitis. Annals of internal medicine, 1999, Jun-01, Volume: 130, Issue:11 Topics: Acute Disease; Adult; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Cyclohexanols; Female; Humans; Venlafaxine Hydrochloride	1999
Venlafaxine-associated hepatitis. Annals of internal medicine, 2000, Mar-07, Volume: 132, Issue:5 Topics: Aged; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Cyclohexanols; Humans; Liver Function Tests; Male; Venlafaxine Hydrochloride	2000